Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)

CAPS Rating:

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.